Loading...

Notable Labs, Ltd.

NTBLNASDAQ
Healthcare
Biotechnology
$0.25
$-0.09(-27.68%)

Notable Labs, Ltd. (NTBL) Stock Overview

Explore Notable Labs, Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.6/100

Key Financials

Market Cap2.4M
P/E Ratio-0.26
EPS (TTM)$-1.09
ROE-0.96%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.07

NTBL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Notable Labs, Ltd. (NTBL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.07.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.26 and a market capitalization of 2.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;